New hybrid 'NOSH aspirin' as possible anti-cancer drug - Scientists have combined two new "designer" forms of aspirin into a hybrid substance that appears more effective than either of its forebears in controlling the growth of several forms of cancer in laboratory tests. Their report on the new NOSH-aspirin, so named because it releases nitric oxide (NO) and hydrogen sulfide (H2S), appears in the journal ACS Medicinal Chemistry Letters.
Email Newsletter
David Bradley
Slinn Pickings
ChemSpy.com is owned and operated by science journalist David Bradley. Additional chemistry news updates are posted by chemist Robert Slinn CChem MRSC MPhil with the tag: Slinn Pickings.
About